Key result
Anticoagulant therapy for venous thromboembolism has reduced associated morbidity and mortality, despite unanswered questions regarding heparin preparations, administration, and optimal duration.
Answers are grounded in this paper and cite their sources.
Anticoagulant therapy has reduced morbidity and mortality associated with venous thromboembolism, despite ongoing questions about optimal heparin use.
Many questions about anticoagulant therapy, such as whether heparin preparations differ in effectiveness, the best method of heparin administration, and optimum duration of therapy, are still unanswered. However, extensive experimental and clinical experience has led to a closer consensus about some aspects of therapy, and morbidity and mortality associated with venous thromboembolism have been reduced.
No takes yet. Share an insight, caveat, or question.
William W. Coon (1978) conducted a review in venous thromboembolism. Anticoagulant therapy was evaluated. Anticoagulant therapy for venous thromboembolism has reduced associated morbidity and mortality, despite unanswered questions regarding heparin preparations, administration, and optimal duration.
Synapse has enriched 10 related papers. Consider them for comparative context: